Azithromycin PensA
Italy
Table of Contents
Patient Information Leaflet
AZITHROMYCIN PENSA 500 mg film-coated tablets
Generic Medicine
Please read all of this leaflet carefully before you take this medicine because it contains important information for you.
- Keep this leaflet. You may need to read it again.
- If you have any questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not give it to other people, even if their symptoms are the same as yours, as it may be harmful.
- If you experience any adverse reactions, including those not listed in this leaflet, contact your doctor or pharmacist. See section 4.
Contents of this leaflet:
- What AZITHROMYCIN PENSA is and what it is used for
- What you need to know before taking AZITHROMYCIN PENSA
- How to take AZITHROMYCIN PENSA
- Possible side effects
- How to store AZITHROMYCIN PENSA
- Contents of the pack and other information
1. What AZITROMICINA PENSA is and what it is used for
AZITROMICINA PENSA contains the active substance azithromycin. Azithromycin is an antibiotic
that belongs to a group of antibiotics called "macrolides", which inhibit the growth of
susceptible bacteria.
AZITROMICINA PENSA is taken to treat the following infections:
Adults and adolescents weighing 45 kg or more
- infections of the tonsils (tonsillitis) or throat (pharyngitis) caused by streptococcal bacteria
- bacterial infections of the paranasal sinuses (sinusitis)
- bacterial infections of the middle ear (otitis media)
- lung infection (community-acquired pneumonia, not contracted in hospital)
- bacterial infections of the skin and underlying tissues
- bacterial infections of the gums (periodontitis) or gum abscess (periodontal abscess)
- infections of the urethra and cervix caused by the bacterium Chlamydia trachomatis
- bacterial genital infections with painful sores (chancroid)
Adults
- bacterial infections in patients with long-term inflammation of the bronchi (chronic bronchitis)
2. What you need to know before taking AZITHROMYCIN PENSA
Do not take AZITHROMYCIN PENSA
- if you are allergic to azithromycin, erythromycin, other antibiotics known as "macrolides" or "ketolides", or to any of the other ingredients of this medicine (listed in section 6);
Warnings and precautions
Talk to your doctor or pharmacist before taking AZITHROMYCIN PENSA if you have or have had any of the following conditions:
- heart problems (e.g. irregular heartbeat or heart failure) or low levels of potassium or magnesium in the blood: these conditions may contribute to serious cardiac side effects caused by azithromycin;
- liver problems: your doctor may need to monitor liver function or discontinue treatment;
- severe diarrhoea after taking other antibiotics;
- localized muscle weakness (myasthenia gravis), as symptoms of this disease may worsen during treatment;
- or if you are taking ergot derivatives such as ergotamine (used to treat migraine), as these medicines must not be taken together with AZITHROMYCIN PENSA.
Stop taking this medicine and contact your doctor immediately (see also “Serious side effects” in section 4):
- if you suspect you are having an allergic reaction (e.g. difficulty breathing, swelling of the face or throat, rash, blisters);
- if you notice any of the symptoms described in section 4 related to serious skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis (AGEP), reported in association with azithromycin treatment;
- if you experience abnormal heartbeat or palpitations, dizziness or fainting while taking AZITHROMYCIN PENSA;
- if you develop signs of liver problems (e.g. dark urine, loss of appetite, or yellowing of the skin or whites of the eyes);
- if you develop severe diarrhoea during or after treatment. Do not take any medicine for diarrhoea without first consulting your doctor. If diarrhoea persists or recurs within the first weeks of treatment, inform your doctor.
Superinfection
Your doctor may monitor symptoms of additional bacterial or fungal infections that cannot be treated with AZITHROMYCIN PENSA (superinfection).
Sexually transmitted infections
Your doctor may perform a test to rule out possible syphilis infection, a sexually transmitted disease that might otherwise progress undetected and be diagnosed late. Furthermore, in cases of bacterial sexually transmitted infections, your doctor will perform follow-up laboratory tests to monitor the effectiveness of treatment.
Children and adolescents
If your body weight is less than 45 kg, other azithromycin-containing medicines may be more suitable and easier for you to take.
Other medicines and AZITHROMYCIN PENSA
Inform your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Taking AZITHROMYCIN PENSA together with other medicines may cause side effects.
Therefore, it is especially important that you inform your doctor if you are taking any of the following medicines:
- atorvastatin and other statins (to lower cholesterol in the blood and prevent heart disease, including heart attacks and stroke);
- cyclosporine (to prevent organ transplant rejection);
- colchicine (for the treatment of gout and familial Mediterranean fever);
- dabigatran (to prevent and treat blood clots (anticoagulant));
- digoxin (for the treatment of heart conditions);
- warfarin or similar medicines used to thin the blood (anticoagulants);
- medicines that may cause the heart muscle to take longer than usual to contract and relax (QT interval prolongation), such as:
- quinidine, procainamide, dofetilide, amiodarone, and sotalol (for the treatment of irregular heartbeat, including cases of heartbeat that is too fast or too slow – cardiac arrhythmia);
- pimozide (for the treatment of mental illnesses);
- citalopram (for the treatment of depression);
- moxifloxacin and levofloxacin (antibiotics);
- cisapride (for the treatment of gastrointestinal disorders);
- hydroxychloroquine or chloroquine (for the treatment of autoimmune diseases, including rheumatoid arthritis, or for treating or preventing malaria).
Pregnancy and breastfeeding
If you are pregnant, think you may be pregnant, are planning to become pregnant, or are breastfeeding, consult your doctor or pharmacist before taking this medicine.
Pregnancy
Your doctor will decide whether you can take this medicine during pregnancy, after ensuring that the benefits outweigh the potential risks.
Breastfeeding
AZITHROMYCIN PENSA passes into breast milk. Therefore, your doctor will decide whether to discontinue breastfeeding or to avoid treatment with AZITHROMYCIN PENSA, taking into account both the benefit of breastfeeding for the child and the benefit of therapy for you.
Driving and using machines
AZITHROMYCIN PENSA may moderately affect the ability to drive and use machines. Dizziness, drowsiness, seizures, and vision or hearing problems have been reported in some people taking AZITHROMYCIN PENSA. These possible side effects may impair your ability to drive or operate machinery.
AZITHROMYCIN PENSA contains lactose
This medicine contains lactose. If you have been diagnosed by your doctor with an intolerance to certain sugars, contact your doctor before taking this medicine.
AZITHROMYCIN PENSA contains sodium
This medicine contains less than 1 mmol (23 mg) of sodium per tablet, i.e. essentially 'sodium-free'.
3. How to take AZITROMICINA PENSA
Take this medicine exactly as directed by your doctor or pharmacist.
If you have any doubts, consult your doctor or pharmacist.
The dose of AZITROMICINA PENSA you need to take each day depends on the bacterial infection being treated and the specific treatment regimen prescribed by your doctor or pharmacist.
Adults and adolescents with body weight equal to or greater than 45 kg
| Infection | Course of azithromycin treatment |
| Strep throat (tonsillitis) or sore throat (pharyngitis) caused by streptococcal bacteria Bacterial infections of the sinuses (sinusitis) Bacterial infections of the middle ear (otitis media) Bacterial infections in patients with long-term bronchial inflammation (chronic bronchitis)* Lung infection (community-acquired pneumonia, not contracted in hospital)# Bacterial skin and underlying tissue infections Bacterial gum infections (periodontitis) or gum abscess (periodontal abscess) | For these infections, a 3-day treatment course is recommended; below is described the amount of AZITROMICINA PENSA to be taken each day for these treatment courses. 3-day treatment course: 500 mg taken once daily for 3 days. |
| Infections of the urethra and cervix caused by the bacterium Chlamydia trachomatis | 1000 mg taken as a single dose |
| Bacterial genital infections with painful sores (chancroid) | 1000 mg taken as a single dose |
| *for adult patients only #for adult patients, oral treatment may follow an initial intravenous treatment | |
Use in children and adolescents
If your weight is less than 45 kg or you are unable to swallow this medicine, please consult your
doctor or pharmacist, as other azithromycin-containing medicines are available which may be more suitable for you.
Method of administration
For oral use.
AZITROMICINA PENSA should be taken orally as a single daily dose. The tablets must be swallowed whole with water, with or without food. Taking this medicine just before a meal may help improve gastrointestinal tolerability.
If you take more AZITROMICINA PENSA than you should
If you take more AZITROMICINA PENSA than you should, you may feel unwell. Typical signs of overdose include vomiting, diarrhoea, abdominal pain and nausea. Inform your doctor immediately or contact the emergency department of the nearest hospital.
If you forget to take AZITROMICINA PENSA
If you forget to take AZITROMICINA PENSA, take it as soon as possible, provided that at least 12 hours remain before the next dose. If less than 12 hours remain before the next dose, do not take the missed dose; instead, take the next dose at the usual time. Do not take a double dose to make up for a forgotten dose.
If you stop taking AZITROMICINA PENSA
If you stop treatment with AZITROMICINA PENSA too early, the infection may recur. Continue taking AZITROMICINA PENSA for the full duration of treatment, even if you start to feel better.
If you have any questions about the use of this medicine, consult your doctor, pharmacist or nurse.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious side effects
Stop using AZITROMICINA PENSA and contact your doctor immediately if you notice any of the following symptoms:
- sudden wheezing, breathing difficulties, swelling of the eyelids, face or lips, rash or itching mainly affecting the whole body (anaphylactic reaction, frequency not known)
- fast or irregular heartbeat (cardiac arrhythmia or torsades de pointes, tachycardia, frequency not known)
- dark urine, loss of appetite, or yellowing of the skin or whites of the eyes, signs of liver problems (hepatic failure or hepatic necrosis, frequency not known)
- severe diarrhoea with abdominal cramps, blood in the stools and/or fever, which may indicate an infection of the large intestine (antibiotic-associated colitis, frequency not known). Do not take medicines for diarrhoea that inhibit intestinal movements (antiperistaltics)
- red, flat spots on the trunk, target-shaped or circular rashes, often with central blisters, skin peeling, mouth, throat, nose, genital or eye ulcers. These serious skin reactions may be preceded by fever and flu-like symptoms (Stevens-Johnson syndrome or toxic epidermal necrolysis, frequency not known)
- widespread rash, high body temperature and swollen lymph nodes (DRESS syndrome or drug hypersensitivity syndrome, rare (may affect up to 1 in 1,000 people))
- widespread, red, scaly rash with subcutaneous bumps and blisters, accompanied by fever. Symptoms usually appear at the beginning of treatment (acute generalized exanthematous pustulosis, rare (may affect up to 1 in 1,000 people)).
Other side effects
Very common (may affect more than 1 in 10 people)
- diarrhoea
Common (may affect up to 1 in 10 people)
- headache
- vomiting, stomach pain, feeling unwell (nausea)
- changes in blood test results (decreased lymphocyte count, increased eosinophil count, increased basophil count, increased monocyte count, increased neutrophil count, decreased blood bicarbonate).
Uncommon (may affect up to 1 in 100 people)
- candidiasis (fungal infection of the mouth and vagina), other fungal infections
- lung infection, bacterial throat infection, gastrointestinal inflammation, respiratory disorder, inflammation of the nasal mucosa, vaginal infection
- changes in white blood cell count (leucopenia, neutropenia, eosinophilia)
- increased platelet count
- reduced percentage of all blood cells in total blood volume (reduced haematocrit)
- allergic reactions, swelling of the hands, feet and face (angioedema)
- loss of appetite
- nervousness, difficulty sleeping (insomnia)
- dizziness, drowsiness (somnolence), altered sense of taste (dysgeusia), tingling sensation (paraesthesia)
- visual disturbances
- ear disorder
- sensation of dizziness (vertigo)
- awareness of heartbeat (palpitations)
- hot flush
- sudden wheezing, nosebleeds
- constipation, intestinal gas, impaired digestion (dyspepsia), inflammation of the stomach lining (gastritis), difficulty swallowing (dysphagia), bloated abdomen, dry mouth, belching, mouth ulcers, increased salivation
- rash, itching, urticaria, dermatitis, dry skin, abnormally increased sweating (hyperhidrosis)
- swelling and pain in joints (osteoarthritis), muscle pain, back pain, neck pain
- painful urination (dysuria), kidney pain
- irregular menstrual bleeding (metrorrhagia), testicular disorder
- swelling due to fluid retention, particularly in the face, ankles and feet (edema, facial edema, peripheral edema)
- weakness, fatigue, general malaise, fever
- chest pain, pain
- abnormal laboratory test results (e.g. blood or liver tests)
- post-procedural complication
Rare (may affect up to 1 in 1,000 people)
- sensation of irritation
- liver problems, yellowing of the skin or eyes
- increased sensitivity to sunlight
Not known (frequency cannot be estimated from the available data)
- reduced number of red blood cells due to increased cell breakdown, which may cause fatigue and pale skin (haemolytic anaemia)
- reduced number of platelets, which may lead to bleeding and bruising (thrombocytopenia)
- feeling angry, aggressive, fearful or worried (anxiety), acute confusional state (delirium)
- hallucination
- fainting (syncope)
- seizures (convulsions)
- reduced sensitivity to touch, pain and temperature (hypoesthesia)
- feeling hyperactive
- changes in sense of smell (anosmia, parosmia)
- complete loss of taste (ageusia)
- muscle weakness (myasthenia gravis)
- abnormal electrocardiogram (ECG) (prolongation of QT interval)
- deafness, reduced hearing or ringing in the ears (tinnitus)
- low blood pressure
- inflammation of the pancreas causing severe abdominal and back pain (pancreatitis)
- change in tongue colour
- joint pain (arthralgia)
- inflammation of the kidneys (interstitial nephritis) and impaired kidney function
Reporting of side effects
If you experience any side effects, including those not listed in this leaflet, please inform your doctor or pharmacist. You can also report side effects directly via the national reporting system at http://www.aifa.gov.it/content/segnalazioni-reazioni-avverse. By reporting side effects, you can help provide more information on the safety of this medicine.
5. How to store AZITHROMYCIN PENSA
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging after "Exp.".
The expiry date refers to the last day of that month.
Store below 30 °C.
Do not dispose of medicines via wastewater or household waste. Ask your pharmacist how to
dispose of medicines you no longer use. This will help protect the environment.
6. Package contents and other information
What AZITROMICINA PENSA contains
- The active substance is azithromycin dihydrate. Each tablet contains 524.1 mg of azithromycin dihydrate, equivalent to 500 mg of azithromycin.
- The other ingredients are anhydrous calcium hydrogen phosphate, pregelatinized starch, sodium lauryl sulfate, sodium croscarmellose, sodium carmellose, anhydrous colloidal silica, magnesium stearate. Coating: hypromellose (E464), titanium dioxide (E171), triacetin (E1518), monohydrate lactose.
Description of the appearance of AZITROMICINA PENSA and package contents
Pack containing 3 film-coated tablets of 500 mg.
Marketing Authorization Holder
Towa Pharmaceutical S.p.A.
Via Enrico Tazzoli, 6
20154 Milan
Italy
Manufacturer
Doppel Farmaceutici Srl
Via Volturno, 48
20089 Quinto De’ Stampi - Rozzano (Milan)